Company Arca Biopharma Inc Nasdaq
Equities
US00211Y4070
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 30/09/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 09/05/21 |
Sharon Perry
LAW | General Counsel | - | 31/12/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 15/02/17 |
Robert Conway
CHM | Chairman | 70 | 02/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 30/04/07 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 14/06/22 |
James Flynn
BRD | Director/Board Member | 43 | 14/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,507,143 | 14,320,024 ( 98.71 %) | 0 | 98.71 % |
Company contact information
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |